Treating Diabetes: A Comprehensive list of Resources in APA Bibliographic Format Abdel-Wahab, Y. (2008).

University of ulster news release - frog secretions could offer diabetes treatment hope. Retrieved 11/28/2008, 2008, from http://news.ulster.ac.uk/releases/2008/3654.html This article seeks to explain how secretions from the skin of a South American frog could provide a new treatment for diabetes.

Alvey, L. (2006). FDA approves new treatment for diabetes. Retrieved 11/28/2008, 2008, from http://www.fda.gov/bbs/topics/NEWS/2006/NEW01492.html The Food and Drug Administration (FDA) announced the approval of Januvia (sitagliptin phosphate) Tablets, the first diabetes treatment approved in a new class of drugs known as DPP-4 inhibitors that enhances the body's own ability to lower elevated blood sugar.

American Diabetes Association. (2007). Standards of medical care in diabetes: 2007. Diabetes Care, 30, 4. Retrieved from PubMed database. This article, published by the ADA, seeks to offer diabetics and medical specialists standardized tools for evaluating and caring for diabetes. The article addresses a wide range of topics related to diabetes. In terms of addressing new and appropriate treatment practices, the following session will offer the most help: "VII: Diabetes Care in Different Populations" and "XI: Strategies for Improving Diabetic Care."

American Diabetes Association. (2008). Diabetes care journal. Retrieved 11/28/2008, 2008, from http://care.diabetesjournals.org/ Diabetes Care is a journal for the health care practitioner that is intended to increase knowledge, stimulate research, and promote better management of people with diabetes. To achieve these goals, the journal publishes original research on human studies in the following five categories: 1) Clinical Care, Education, Nutrition, and Psychosocial Research, 2) Epidemiology/Health Services Research, 3) Emerging Treatments and Technologies, 4) Pathophysiology/Complications, and 5) Cardiovascular and Metabolic Risk. The journal also publishes clinically relevant review articles, letters to the editor, and health/medical news or points of view. Topics covered are of interest to clinically oriented physicians, researchers, epidemiologists, psychologists, diabetes educators, and other health professionals.

American Diabetes Association. (2008). Standards of medical care in diabetes: 2008. Diabetes Care, 31, 12. Retrieved from PubMed database. This article, published by the ADA, seeks to offer diabetics and medical specialists standardized tools for evaluating and caring for diabetes. The article addresses a wide range of topics related to diabetes. In terms of

addressing new and appropriate treatment practices, the following session will offer the most help: "VII: Diabetes Care in Different Populations" and "XI: Strategies for Improving Diabetic Care."

American Diabetes Association Home Page. Retrieved 11/28/2008, 2008, from http://www.diabetes.org/home.jsp The American Diabetes Association is leading the fight against the deadly consequences of diabetes and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.

Angel, A. Diabetes research and treatment centre. Retrieved 11/28/2008, 2008, from http://www.drtc.ca/ The Diabetes Research and Treatment Centre (DRTC) is an interdisciplinary centre whose function is to promote research, education and treatment of diabetes in Manitoba. It was established in response to an identified need to link the general public and researchers actively involved in diabetes research and promote the transfer of knowledge of new science to the public.

Barnard, N. D. (2007). Dr. neal barnard's program for reversing diabetes: The scientifically proven system for reversing diabetes without drugs. New York, NY: Rodale: Distributed to the trade by Holtzbrinck Publishers. Until Dr. Barnard’s scientific breakthrough, most health professionals believed that once you developed diabetes, you were stuck with it—and could anticipate one complication after another, from worsening eyesight and nerve symptoms to heart and kidney problems. But as this groundbreaking work reveals, this simply is not true. In a series of studies—the most recent funded by the National Institutes of Health—Dr. Barnard has shown that it is possible to repair insulin function and reverse type 2 diabetes. By following his scientifically proven, life-changing program, diabetics can control blood sugar three times more effectively than with the standard diet; and cut back on and in some cases eliminate medications while reducing the risk of diabetes complications.

Brownlee, C. (2007). Hopkins diabetes experts available. Retrieved November 17, 2008, 2008, from http://www.hopkinsmedicine.org/Press_releases/2007/11_09_07.html If you are looking for new treatment option for diabetes, please consider calling on experts from the Johns Hopkins Comprehensive Diabetes Center. With diabetes specialists ranging from clinical endocrinologists to nutritionists to scientists who perform basic research, the Diabetes Center can provide you with unique sources who can answer your questions about this ever-growing disease. To schedule an interview with any of these diabetes experts, please contact Christen Brownlee at 410-955-7832.

Cadre: Council for the advancement of diabetes research and education. Retrieved 11/28/2008, 2008, from http://www.cadre-diabetes.org/ CADRE is a non-profit organization committed to reducing the burden of diabetes by providing health care professionals with scientific information and educational initiatives designed to translate research into effective clinical practice.This website is an excellent resource for individuals seeking to learn about new research for diabetes treatment.

Canadian diabetes association. (2008). Retrieved 11/28/2008, 2008, from http://www.diabetes.ca/ The Canadian Diabetes Association is a leading expert and authority on diabetes in Canada – and around the world. We have a heritage of excellence and leadership that started with our co-founder and co-discoverer of insulin, Dr. Charles Best. Since that time, we have continued to deliver programs and services for people affected by diabetes. We fund leading-edge diabetes research and produce globally recognized diabetes guidelines. We advocate on behalf of those affected and share the latest information with the public and the healthcare community.

Chandra, S. T., Priya, G., Khurana, M. L., Jyotsna, V. P., Sreenivas, V., Dwivedi, S., et al. (2008). Comparison of gliclazide with insulin as initial treatment modality in newly diagnosed type 2 diabetes. Diabetes Technology & Therapeutics, 10(5), 363-368. This study was designed to compare effectiveness and remission rate between gliclazide and insulin as initial treatment in newly diagnosed, drug-naive patients with type 2 diabetes.

Comeau, P. (2007). New diabetes treatment and prevention strategies needed. CMAJ: Canadian Medical Association Journal, 176(10), 1401-1402. The article reports on the need for an aggressive team-based treatment and prevention strategies to reverse the upward trend in diabetes rates across Canada, according to the Health Council of Canada. The process will require a shifty in health care attitudes from the current "find-it-and-fix-it" approach to a more comprehensive "prevent it" strategy.

Diabetes australia: Turning diabetes around. (2008). Retrieved 11/28/2008, 2008, from http://www.diabetesaustralia.com.au/ Diabetes Australia is the national peak body for diabetes in Australia providing a single, powerful, collective voice for people living with diabetes, their families and carers. Diabetes Australia works in partnership with diabetes health professionals, educators and researchers to minimise the impact of diabetes on the Australian community.

Diabetes Australia is committed to turning diabetes around through awareness, prevention, detection, management and a cure.

Diabetes experts win top scientific honors.(2007, July/August 2007). Medicine@Yale. Retrieved from http://www.medicineatyale.org/v3i4_july_aug_2007/honors.html Two School of Medicine scientists have received high honors for their contributions to diabetes research and treatment. Robert S. Sherwin, M.D., the C.N.H. Long Professor of Medicine and director of the Yale Center for Clinical Investigation, is the winner of the 2007 Banting Medal for Scientific Achievement Award from the American Diabetes Association (ADA), the association’s highest honor for diabetes researchers. Gerald I. Shulman, M.D., Ph.D., professor of medicine and of cellular and molecular physiology, was elected to the National Academy of Sciences (NAS), one of the highest honors in American science and engineering.

Diabetes forecast online. (2008). Retrieved 11/28/2008, 2008, from http://www.forecast.diabetes.org/ Each month, nearly 4.4 million readers turn to Diabetes Forecast for the latest and best information on diabetes and treatment, and for practical tips on day-to-day coping with diabetes. Each full-color issue is filled with helpful hints ... on eating well, beating stress, staying active, getting support, and finding great diabetes care.

Diabetes health magazine online.(2008). , November 20, 2008. Diabetes Health magazine is the essential resource for living long and well with diabetes. Both the print and electronic versions seek to help people with diabetes by investigating new treatments, keeping them informed, and inspiring them to continue to fight the epidemic that diabetes has become.

Diabetes india: The indian task force on diabetes treatment and research. Retrieved 11/28/2008, 2008, from http://www.diabetesindia.com/ More than 30 Million People (in India) know they have Diabetes, and the number is climbin steeply. India has the dubious distinction of having the largest number of people with Diabetes. The picture of Diabetes in India is considerably different from that seen in the West, for which most information is available. But managing Diabetes has to be tailored to our Indian needs. It is all very well said that the patient and his family physician should take “control” of the disorder, but control comes with power…and power comes with knowledge. The aim of this site is not to assume the role of a doctor, but to “aid and assist” the people with Diabetes and their treating physicians with the latest in “knowledge,” thus giving them the power to take control of Diabetes.

Diabetes monitor: Monitoring diabetes happenings everywhere in cyberspace, and providing information, education and support for people with diabetes.(2008). 2008(11/28/2008)

It is the mission of the Diabetes Monitor to provide information about Diabetes for patients and their families, and offer useful advice about the prevention and management of diabetic complications; provide resources for patients, families, diabetes educators and other health care professionals; and support people with diabetes in their pursuit of quality of life.

Diabetes New Zealand. (2008). Retrieved 11/28/2008, 2008, from http://www.diabetes.org.nz/ Diabetes New Zealand is an incorporated society, and is a nationwide, non-governmental, non-profit organization. Established in February 1962, the aim of the organization is to support its 14,000 members, 39 diabetes societies throughout New Zealand, and health professionals involved with diabetes. Diabetes New Zealand acts for people affected by diabetes by encouraging local support for people affected by diabetes, acting as an advocate for people affected by diabetes, raising awareness of diabetes, especially concerning interventions that will prevent or reduce its incidence, educating and informing people about diabetes, its treatment, management and control, and supporting research into the treatment, prevention, and cure of diabetes.

Diabetes research institute. (2008). Retrieved 11/28/2008, 2008, from http://www.diabetesresearch.org/DiabetesResearchInstitute.htm The Diabetes Research Institute (DRI) is a recognized world leader in cure-focused research. Since its inception in the early 1970s, the DRI has made significant contributions to the field of diabetes research, pioneering many of the techniques used in islet cell transplantation. From innovations in islet isolation and transplant procedures to advances in cell biology and immunology, the Diabetes Research Institute is now harnessing the power of emerging technologies to develop new cell-based therapies to restore insulin production.

Diabetes treatment: YouTube videocast from NewsCanada. (April 3, 2007). Retrieved 11/28/2008, 2008, from http://www.youtube.com/watch?v=v9ocluhyc2M Controlling blood sugar is a crucial part of managing diabetes, and a new insulin treatment is offering patients a simple and convenient way to keep those levels under control. This video, produced by Newscanada, describes that new insulin treatment. From April 2005.

Diabetes UK home page-the charity for people with diabetes. (2008). Retrieved 11/28/2008, 2008, from http://www.diabetes.org.uk/ Diabetes UK is the charity for people with diabetes, their family, friends and carers. Our mission is to improve the lives of people with the condition and work towards a future without diabetes. We are one of the largest patient organizations in Europe. We stand up for the interests of people with diabetes by campaigning for better standards of care. We are the largest funder in the UK of research into better treatments for diabetes and the

search for a cure. We provide practical support and information and safety-net services to help people manage their diabetes.

Diabetes UK: The global diabetes community. (2008). Retrieved 11/28/2008, 2008, from http://www.diabetes.co.uk/ The primary aim of Diabetes.co.uk is to reduce the suffering of others without exploiting any individual being. We aim to improve the physical, psychological and mental health of our visitors. We aim to be completely environmentally and socially accountable for all our personal and business actions, both relating to Diabetes.co.uk and within our daily lives. This website provides a plethora of diverse, innovative, and important tools for people with diabetes.

Drucker, D. J., Buse, J. B., Taylor, K., Kendall, D. M., Trautmann, M., Zhuang, D., et al. (2008). Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: A randomized, open-label, non-inferiority study. Lancet, 372(9645), 1240-1250.

Easton, J. (2005). Steiner symposium brings together leading diabetes experts. Retrieved November 17, 2008, 2008, from http://www.uchospitals.edu/news/2005/20050705-steiner.html On Friday, July 15, 2005, 28 of the world's leading diabetes researchers gathered at the at the University of Chicago's Biological Sciences Learning Center to discuss their latest research in diabetes treatment.

FC&A Medical Publishers (Ed.). (2007). Amazing diabetes breakthroughs: Natural remedies and medical miracles that really work. Peachtree City, GA: FC&A Medical Publishing. This is a pamphlet that addresses the following topics related to Diabetes: Blood sugar basics, The Glycemic Index, Diet defense, Slimming Down, The Stress connection, Active living, and the Next Defense.

Gadsby, R. (2008). Management of type-2 diabetes. GP: General Practitioner, , 25-26. Expert Dr. Roger Gadsby reviews the new diabetes management guidelines from NICE.

Groves, B. Diabetes information point - second opinions, UK. Retrieved 11/28/2008, 2008, from http://www.secondopinions.co.uk/diabetes_index.html This is a series of pages outlining the present state of conventional diabetes treatment, why it is wrong, and the evidence for a better, healthier way not just to treat diabetes, but also to cure the condition and to prevent it.

Hampton, T. (2006). Stem cells probed as diabetes treatment. JAMA: Journal of the American Medical Association, 296(23), 2785-2786. Information about several topics discussed at the New York Stem Cell Foundation's Translation Stem Cell

Research Conference in 2006 is presented. The article addresses the role of stem cell research in diabetes treatment. According to the author, type 1 diabetes is particularly hard to treat because of the pancreas, which is poor at regeration, and beta cells, which produce insulin. Quotes from Douglas Melton, a doctor at the Harvard Stem Cell Institute at Harvard University in Cambridge, Massachusetts, are presented.

Hanaire, H., Lassmann-Vague, V., Jeandidier, N., Renard, E., Tubiana-Rufi, N., Vambergue, A., et al. (2008). Treatment of diabetes mellitus using an external insulin pump: The state of the art. Diabetes & Metabolism, 34(4), Supplement 1. This article seeks to inform diabetic patients who are interested in the insulin pump therapy about the different aspects of that treatment. An in-depth abstract is available from PubMed: (http://www.ncbi.nlm.nih.gov/pubmed/18951116? ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed _RVDocSum)

Hawley, J. A., & Zierath, J. R. (Eds.). (2008). Physical activity and type 2 diabetes: Therapeutic effects and mechanisms of action. Champaign, IL: Human Kinetics. For those engaged in a struggle against diabetes, Physical Activity and Type 2 Diabetes provides cutting-edge research to energize current efforts in diabetes prevention, management, and treatment. The most in-depth and up-to-date book on the topic, Physical Activity and Type 2 Diabetes presents a series of independent but related chapters authored by the foremost researchers of insulin resistance examining topics such as these:Physical inactivity as a primary cause for the rising incidence of insulin resistance; The emergence of an "exercisedeficient" phenotype; The effects of exercise training on selected aspects of substrate metabolism; The role of endurance and resistance training programs for the prevention and treatment of insulin resistance; The identification of new molecular targets and pathways useful for the treatment of insulin resistance and type 2 diabetes. Physical Activity and Type 2 Diabetes provides a four-part, in-depth examination of the relational nature of diabetes and physical activity.

Holt, E. H. (2008). MedlinePlus medical encyclopedia: Diabetes. Retrieved 11/28/2008, 2008, from http://www.nlm.nih.gov/medlineplus/ency/article/001214.htm This is an online encyclopedia provided by the United States Library of Medicine and the United States National Institutes of Health. It provides links to articles related to a variety of health topics. This particular link offers information on diabetes diagnosis and treatment.

Illinois institute of technology: Center for diabetes research and policy. Retrieved 11/28/2008, 2008, from http://www.iitdiabetes.org/ IIT's Center for Diabetes Research and Policy combines the research strengths of Illinois Institute of Technology's department of biomedical engineering with the legal expertise of Chicago-Kent College of Law. IIT researchers affiliated with the CDRP use engineering techniques to develop treatment modalities for diabetes and its many complications and to advance diabetes prevention strategies.

Insulin by inhaler: New option for diabetes treatment.(2006). Harv.Womens Health Watch, 13(8), 5-5. Retrieved from http://search.ebscohost.com/login.aspx?direct=true&db=hch&AN=20205361&site=ehost-live Provides information on Exubera, a fast-acting inhaled insulin for diabetes treatment approved by the U.S. Food and Drug Administration in January 2006. Overview of insulin treatment for diabetes in the country; Mechanism of action and mode of use of the drug; Potential risks factors for using inhaled insulin treatment method.

The Islet Foundation: A final push in the cure for diabetes. Retrieved 11/28/2008, 2008, from http://www.islet.org/index.htm For the last thirty years, research at universities and private labs has moved slowly toward achieving a cure for insulin-dependent diabetes. The Islet Foundation (TIF) is dedicated to supporting the "final push" for that research effort, a push that may provide a safe and viable cure for millions of diabetics. Other charitable foundations provide essential funding to the broad spectrum of diabetic needs, including education, training, supplies, legal issues, and basic research. Their activities have improved the lives of many diabetics, but have frequently failed to support research initiatives that are likely to deliver a near-term cure for diabetes. The Islet Foundation is different, focusing its resources to advance one specific line of research from the laboratory to human trials and, ultimately, to a routine cure for insulin-dependent diabetes. Rather than spread its resources among many diabetic management and research initiatives, TIF is betting on a single body of research, one which many researchers feel is the most likely to result in a near-term cure. TIF is focusing on islet replacement without immunosuppression, a procedure which many believe will allow people with diabetes to continuously maintain normal blood sugar levels, without the crude intervention of injected insulin, and without the many short-term and long-term problems associated with this process of disease management. Within the broad spectrum of islet replacement, there are a number of promising directions, including islet xenotransplantation, islet cell engineering, islet cell expansion, and islet neogenesis. Each of these initiatives has its own set of advantages and challenges. Some approaches hold the promise of near term relief from the consequences of crudely controlled blood glucose, and some represent subsequent generations of improved treatment.

Jones, P. M., Courtney, M. L., Burns, C. J., & Persaud, S. J. (2008). Cell-based treatments for diabetes. Drug Discovery Today, 13(19), 888-893. This article offers a scientific explanation of the benefits and drawbacks of cell-replacement therapies as a means of treating diabetes.

Juhn, G., & Stacy, K. (2008). MedlinePlus medical encyclopedia: Diabetes - resources. Retrieved 11/28/2008, 2008, from http://www.nlm.nih.gov/medlineplus/ency/article/002179.htm This is an online encyclopedia provided by the United States Library of Medicine and the United States National Institutes of Health. It provides links to articles related to a variety of health topics. This particular website offers a wide variety of links to resources for people dealing with diabetes.

Khalangot, M., Tronko, M., Kravchenko, V., Kulchinska, J., & Hu, G. (2008). The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes. Diabetes Research & Clinical Practice, 82(1), 139-147. The objective of this article is to compare the joint effects of different types of glucose-lowering treatment (oral drugs, insulin, and both) and duration of diabetes on total and cardiovascular mortality among diabetic patients.

LeRoith, D., & Vinik, A. I. (Eds.). (2008). Controversies in treating diabetes: Clinical and research aspects. Totowa, NJ: Humana Press. The book Controversies in Treating Diabetes demonstrates that valuable knowledge can be gained from studying controversial topics in the field of diabetes. The book is part of the Contemporary Endocrinology series from Humana Press, whose target audience is practicing endocrinologists and researchers. The editors, Derek LeRoith and Aaron Vinik, faced a challenging task: they set out to address both the clinical and the research aspects of diabetes.

Luo, J. Z., & Luo, L. (2008). Ginseng on hyperglycemia: Effects and mechanisms. ECAM, This review briefly summarizes current knowledge of ginseng components and clinical studies related to diabetes. Further research will be needed to explore and identify the component(s) of ginseng, which may be responsible for the beneficial effects observed in animal studies which could then be extrapolated to human islets.

Madsen, O. D. (2005). Stem cells and diabetes treatment. APMIS: Acta Pathologica, Microbiologica, Et Immunologica Scandinavica, 113(11-12), 858-875. Diabetes mellitus types 1 and 2 are characterized by absolute versus relative lack of insulin-producing beta cells, respectively. Reconstitution of a functional beta-cell mass by cell therapy--using organ donor islets of Langerhans--has been demonstrated to restore euglycaemia in the absence of insulin treatment. This remarkable

achievement has stimulated the search for appropriate stem cell sources from which adequate expansion and maturation of therapeutic beta cells can be achieved. This recent activity is reviewed and presented with particular focus on directed differentiation from pluripotent embryonic stem cells (versus other stem/progenitor cell sources) based on knowledge from pancreatic beta-cell development and the parallel approach to controlling endogenous beta-cell neogenesis.

Marshfield clinic home page for patients & visitors. (2008). Retrieved 11/28/2008, 2008, from http://www.marshfieldclinic.org/patients/ This page provides links to Marshfield Clinic's various departments. It is a good resource for individuals seeking medical care in the central Wisconsin region.

Matza, L. S., Boye, K. S., Yurgin, N., Brewster-Jordan, J., Mannix, S., Shorr, J. M., et al. (2007). Utilities and disutilities for type 2 diabetes treatment-related attributes. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 16(7), 1251-1265. Although cost-utility analyses are frequently used to estimate treatment outcomes for type 2 diabetes, utilities are not available for key medication-related attributes. The purpose of this study was to identify the utility or disutility of diabetes medication-related attributes (weight change, gastrointestinal side effects, fear of hypoglycemia) that may influence patient preference.

Ministry health care (wisconsin): Diabetes services. (2008). Retrieved 11/28/2008, 2008, from http://www.ministryhealth.org/MinistryHealth/Services/Diabetes.nws This website seeks to introduce people with diabetes to the tools that Ministry Health of Wisconsin offers for proper medical care, clinical therapies, diet, hygiene, exercise, and symptoms reduction.

Mount sinai hospital: Leadership sinai center for diabetes. (2008). Retrieved 11/28/2008, 2008, from http://www.mountsinai.on.ca/care/lscd The goal of the Leadership Sinai Centre for Diabetes (LSCD) is to be a leader in diabetes care through clinical practice, patient education and research. A team of many different health care professionals provides care that focuses on patients and their families. This information is designed to help you learn about all the services available through the LSCD so that you will be able to become a more active participant in your care. The Centre for Diabetes aims to provide the highest quality diabetes care through the integration of clinical practice, research and education for individuals with diabetes and their families.The Centre is also committed to advancing the practice of health care through actively promoting research and continuing education for health care professionals in areas related to diabetes.

Naomi berrie diabetes center. Retrieved 11/28/2008, 2008, from http://nbdiabetes.org/ The Naomi Berrie Diabetes Center at Columbia University Medical Center, named after Russ Berrie's mother who, like her son, had diabetes, opened in the Russ Berrie Medical Science Pavilion at Columbia University Medical Center in October 1998. The Naomi Berrie Diabetes Center combines unprecedented family-oriented patient care and education with world-class diabetes research programs.

National diabetes information clearinghouse. (2008). Retrieved 11/28/2008, 2008, from http://www.diabetes.niddk.nih.gov/ The National Diabetes Information Clearinghouse (NDIC) is an information dissemination service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK is part of the National Institutes of Health (NIH), which is part of the U.S. Department of Health and Human Services. NDIC was established in 1978 to increase knowledge and understanding about diabetes among patients, health care professionals, and the general public. To carry out this mission, NDIC works closely with NIDDK's Diabetes Research and Training Centers; the National Diabetes Education Program (NDEP); professional, patient, and voluntary associations; Government agencies; and State health departments to identify and respond to informational needs about diabetes and its management.

NIH senior health: Diabetes - treatment - latest research. (2008). Retrieved 11/28/2008, 2008, from http://nihseniorhealth.gov/diabetes/latestresearch/02.html This website, created by the NIH (National Institute of Health), provides an overview of the most up-to-date diabetes research and treatment options. It also provides links for diagnosis and treatment maintenance.

Nobles, R. (2000). Robin's nest: National diabetes month on the internet. Retrieved 11/28/2008, 2008, from http://www.robinsnest.com/articles/diabetes.html The Internet is crammed full of information on virtually any disease or ailment. In honor of National Diabetes Month, we're providing a list of sites about diabetes.

Pasupuleti, V. K., & Anderson, J. W. (Eds.). (2008). Nutraceuticals, glycemic health, and type 2 diabetes (1st ed.). Ames, Iowa: Blackwell Publishing Professionals. Type 2 diabetes is a growing problem for the developed and developing countries and it is a burden on healthcare systems as well as individuals. Nutraceuticals, Glycemic Health and Type 2 Diabetes primarily focuses on the nutraceuticals that assist in preventing and managing prediabetes and type 2 diabetes. The book gives an overview of glycemic health and highlights the use of novel and upcoming nutraceutical ingredients such as bioactive peptides, traditional herbs from India and Mexico, resistant starches, cinnamon, chromium III and

others. After the successful commercial application of bioactive peptides as nutraceutical ingredients in the management of blood pressure, companies are now focusing on peptides for the prevention and management of type 2 diabetes. Resistant starches in the clinical studies have demonstrated to reduce the glycemic and insulin response and increasing insulin sensitivity. These and other nutraceuticals that are supported by scientific and clinical studies are highlighted. The editors and contributors are experts in their respective fields and are largely from the university, industry and government. Nutraceuticals, Glycemic Health and Type 2 Diabetes will be useful as a standard reference book for all those concerned with the role of nutraceuticals and glycemia in the prevention and control of type 2 diabetes.

Planning treatment for diabetes: Resources from the NHS (national health service, UK). (June 26, 2008). Retrieved 11/28/2008, 2008, from http://www.nhs.uk/Pathways/diabetes/Pages/Treatment.aspx?WT.srch=1 The aim of treating diabetes is to help people with the condition to achieve good control of their blood glucose levels and to minimise the risk of developing complications over time. The Department of Health has set out national standards for NHS organisations and professionals covering diabetes care and prevention. The Diabetes National Service Framework was developed by diabetes clinical experts and patients with diabetes.

Primary care diabetes europe. Retrieved 11/28/2008, 2008, from http://www.pcdeurope.org/view/12 PCD Europe exists to provide a focal point for primary care clinicians and their patients. Its purpose is to promote high standards of care throughout Europe. Emphasis is placed on incorporating evidence based medicine into daily practice as well as promoting diabetes education and research in primary care. This website is an excellent source for European diabetes news and research.

Roberts, S. (2008). Turning the corner: Improving diabetes care (UK department of health).(72), 11/28/2008. The Diabetes National Service Framework set out the first ever set of national standards for the treatment of diabetes to raise the quality of NHS services and reduce unacceptable variations between them. This report highlights progress over the first three years following the publication of the NSF Delivery Strategy.

Rosenberg, S. (2008). Diabetes digest. Retrieved 11/28/2008, 2008, from http://www.diabetesdigest.com/ Since 1995, H. Crimson Inc., has been publishing its Diabetes Digest Family of Magazines, the nation's largest circulation diabetes magazines, for America’s top pharmacies. These free customized diabetes magazines, in both English and Spanish, are user-friendly, practical guides written by an esteemed editorial board of diabetes educators and physicians including two winners of the American Association of Diabetes Educators' Diabetes Educator of the Year award. This website offers a free, on-line version of the magazine.

Rosenstock, J., Chou, H. S., Matthaei, S., Seidel, D. K., & Hamann, A. (2008). Potential benefits of early addition of rosiglitazone in combination with glimepiride in the treatment of type 2 diabetes. Diabetes, Obesity & Metabolism, 10(10), 862-873. The goal of this article is to assess the efficacy and tolerability of early combination therapy with rosiglitazone (RSG) and glimepiride (GLIM) vs. GLIM monotherapy in patients with type 2 diabetes mellitus (T2DM).

Sansum diabetes research institute. (2006). Retrieved 11/28/2008, 2008, from http://www.sansum.org/ Sansum Diabetes Research Institute is a research center devoted to the prevention, treatment and cure of diabetes. Dr. William D. Sansum founded the non profit organization in 1944 and brought renown to Santa Barbara in 1922 as the first physician in the U.S. to administer life-saving insulin to patients with diabetes. It is our intention to use our past and present accomplishments to guide us into the future – to tap into the energy and commitment that made Sansum Diabetes Research Institute what it is today – a worldwide leader in diabetes research, prevention, and treatment.

Swedberg, K., Rusk, J., & Adams, S. (2008). TRANSCEND: Telmisartan may be potential treatment for high-risk diabetes, vascular disease. Cardiology Today, 11(10), 11-11. The article presents the results of clinical trial conducted on telmisartan. It references a study presented by Koon K. Teo at the 2008 European Society of Cardiology (ESC) Congress in Munich, Germany. The study involved patients with vascular disease or high-risk diabetes and the result showed the efficacy of telmisartan in reducing cardiovascular death and myocardial infraction. About half of the 5,926 patients who took part in the study received placebo while the rest received 80 mg/day of Micardis, the brand name of telmisartan.

Tanday, S. (2007). Stem cell hope for diabetes treatment. GP: General Practitioner, , 5-5. The article presents information on a research in the U.S., which states that stem cells that pass from mother to child in the womb may lead to a novel treatment for type-1 diabetes. For the study, whole blood samples were collected from 94 individuals with type-1 diabetes, 54 unaffected siblings and 24 unrelated healthy volunteers. According to the research people with type-1 diabetes were found to have around twice as many cells with a maternal origin than unaffected individuals.

University of california center for diabetes treatment and research. (2005). Retrieved 11/28/2008, 2008, from http://www.ucidiabetes.com/ As the major diabetes resource in the community, the University of California Center for Diabetes Treatment & Research identifies the most promising research with the potential to translate into real-world diabetes

treatments. Through outreach, education, research and clinical trials, our staff helps to improve the overall diabetes knowledge base of the communities that we serve: physicians, nurses, educators and patients.

Walsh, J., & Roberts, R. The diabetes mall: Internet links to diabetes resources. Retrieved 11/28/2008, 2008, from http://www.diabetesnet.com/diabetes_resources/publications.php This website gives a list of electronic and print materials that address the needs of people with Diabetes. Resources include E-Newsletters, Dictionaries, Libraries, and Journals that all focus on news and information that is pertinent in the world of Diabetes treatment.

Wilson, A. (2008). How effective is gastric bypass surgery in curing type-2 diabetes? Retrieved 11/28/2008, 2008, from http://healthhubs.net/diabetes/how-effective-is-gastric-bypass-surgery-in-curing-type-2-diabetes/ In emerging trend in the past fifteen years has been the increasing use of gastric bypass surgery as a treatment for morbid obesity. Recent scientific studies have found that not only does gastric bypass surgery lead to a dramatic amount of weight loss, it also results in the remission of diabetes in as many as 90% of cases, often within just a few weeks of the surgery.

Wilson, A. (2008). How effective is gastric bypass surgery in curing type-2 diabetes? Retrieved October 12, 2008, from http://healthhubs.net/diabetes/how-effective-is-gastric-bypass-surgery-in-curing-type-2-diabetes/ Article describing the evolution of gastric bypass surgery from treatment of morbid obesity to treatment option for type II diabetics. Good journal article references.

World diabetes foundation. (2008). Retrieved 11/28/2008, 2008, from http://www.worlddiabetesfoundation.org/ The World Diabetes Foundation is dedicated to supporting prevention and treatment of diabetes in developing countries. We focus on the following areas: Awareness of diabetes, prevention of diabetes and its complications, education and training of patients and health care professionals, and enhancement of detection, treatment, and monitoring of diabetes. We act as a catalyst to build relations among different stakeholders such as governments, diabetes organizations, hospitals, and authorities to ensure continued existence of our initiatives after the completion of the World Diabetes Foundation funded projects.

Yorkshire and humber public health observatory : Diabetes resources. (2008). Retrieved 11/28/2008, 2008, from http://www.yhpho.org.uk/resources_diabetes.aspx This site, created as part of the Yorkshire and Humber Public Health Observatory website, seeks to offer both electronic and print resources to people with diabetes.

Sign up to vote on this title
UsefulNot useful